Skip to search formSkip to main contentSkip to account menu

MHY 218

Known as: MHY-218, MHY218 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A new Brain-Computer Interface (BCI) technique, which is called a hybrid BCI, has recently been proposed to address the… 
2016
2016
Hyperpigmentation caused by melanin overproduction is a major skin disorder in humans. Inhibition of tyrosinase, a key regulator… 
2015
2015
We previously reported the anticancer effects of MHY218, which is a hydroxamic acid derivative, in HCT116 human colon cancer… 
2014
2014
Colorectal cancer (CRC) is one of the most common malignant diseases and frequent cause of cancer deaths in the world. In spite… 
2011
2011
SummaryAcquired resistance to tamoxifen (Tam) is a critical problem in breast cancer therapy. Therefore, new potential strategies… 
2011
2011
In this study, we investigated the anti-proliferative and pro-apoptotic properties of novel hydroxamic acid-derivative, MHY218… 
2010
2010
To investigate the anticancer effects of the novel hydroxamic acid-derived histone deacetylase (HDAC) inhibitor MHY218, its…